Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01989130 · ClinicalTrials.gov registry record · NA
Evaluation of Immediate v. Delayed CT/NG Test for Treatment in the ED
A NA study, sponsored by George Washington University.
- Completed
- Registry status
- NA
- Development phase
- 70
- Enrollment target
NCT01989130: Completed NA study, sponsored by George Washington University.
NCT01989130 is a NA study that has completed, run by George Washington University. The registered enrollment target is 70 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01989130, a NA study, has completed, sponsored by George Washington University.
- COMPLETED
- Registry status
- NA
- Development phase
- 70 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if immediate availability of GeneXpert® CT/NG test results reduces the overtreatment rate for ED patients with suspected gonorrhea or chlamydia and to assess changes in clinician management decisions with real-time test results.
Primary Outcome
Measurement of the number and type of antibiotics prescribed to CT/NG + v. CT/NG - in both groups
Interventions
- DEVICE Roche AMPLICOR CT/NG
- DEVICE Cepheid Xpert CT/NG Test
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2013-10 |
| Est. Completion | 2015-03 |
| Phase | NA |
What the finished NCT01989130 record still lists
NCT01989130 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 70 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 2 interventions - of which Roche AMPLICOR CT/NG is the first listed.
NCT01989130 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01989130 about?
NCT01989130 is a clinical study titled "Evaluation of Immediate v. Delayed CT/NG Test for Treatment in the ED". The purpose of this study is to determine if immediate availability of GeneXpert® CT/NG test results reduces the overtreatment rate for ED patients with suspected gonorrhea or chlamydia and to assess changes in clinician management decisions with real-time test results.
What is the current status of trial NCT01989130?
This trial is currently completed. It is a NA study. The enrollment target is 70 participants. The study started on 2013-10. Estimated completion is 2015-03.
What interventions are being tested in trial NCT01989130?
The interventions under investigation include: Roche AMPLICOR CT/NG (DEVICE), Cepheid Xpert CT/NG Test (DEVICE).
Who is sponsoring clinical trial NCT01989130?
This trial is sponsored by George Washington University, which has 133 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01989130's enrollment target sits among peer trials
70 1103rd of 2000 higher than 868 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00969111 · 70 participants · NA
Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy
- NCT01712620 · 70 participants · Phase 2
Spironolactone for Pulmonary Arterial Hypertension
- NCT02143830 · 70 participants · Phase 2
HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy
- NCT02601339 · 70 participants
NIRS Monitoring in Premature Infants
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia